Genetic and atherosclerotic plaque immunohistochemical analyses do not associate reduced sclerostin expression with cardiovascular events

Gill Holdsworth, James R Staley, Peter Hall, Ian van Koeverden, Ciara Vangjeli, Remi Okoye, Rogely Boyce, James R Turk, Martin Armstrong, Alison Wolfreys, Gerard Pasterkamp
doi: https://doi.org/10.1101/2020.11.20.20235234

Article Information

doi 
https://doi.org/10.1101/2020.11.20.20235234
History 
  • November 23, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Gill Holdsworth1,*,
  2. James R Staley1,
  3. Peter Hall1,
  4. Ian van Koeverden2,
  5. Ciara Vangjeli1,
  6. Remi Okoye1,
  7. Rogely Boyce3,
  8. James R Turk3,
  9. Martin Armstrong4,
  10. Alison Wolfreys1 and
  11. Gerard Pasterkamp2
  1. 1UCB Pharma, Slough, UK
  2. 2University Medical Centre Utrecht, The Netherlands
  3. 3Amgen Inc., Thousand Oaks, CA, USA
  4. 4UCB Pharma, Braine-L’Alleud, Belgium
  1. ↵*Corresponding author Gill.Holdsworth{at}ucb.com
Back to top
Posted November 23, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Genetic and atherosclerotic plaque immunohistochemical analyses do not associate reduced sclerostin expression with cardiovascular events
Gill Holdsworth, James R Staley, Peter Hall, Ian van Koeverden, Ciara Vangjeli, Remi Okoye, Rogely Boyce, James R Turk, Martin Armstrong, Alison Wolfreys, Gerard Pasterkamp
medRxiv 2020.11.20.20235234; doi: https://doi.org/10.1101/2020.11.20.20235234
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area